These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 25745762

  • 1. AMD--the retinal disease with an unprecised etiopathogenesis: in search of effective therapeutics.
    Nowak JZ.
    Acta Pol Pharm; 2014; 71(6):900-16. PubMed ID: 25745762
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ferrara N, Damico L, Shams N, Lowman H, Kim R.
    Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
    [Abstract] [Full Text] [Related]

  • 4. [Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies].
    Nowak JZ, Bienias W.
    Postepy Hig Med Dosw (Online); 2007 Oct; 61():83-94. PubMed ID: 17369776
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bevacizumab and neovascular age related macular degeneration: pathogenesis and treatment.
    El-Mollayess GM, Noureddine BN, Bashshur ZF.
    Semin Ophthalmol; 2011 May; 26(3):69-76. PubMed ID: 21609219
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cellular and molecular mechanisms of age-related macular degeneration: from impaired autophagy to neovascularization.
    Klettner A, Kauppinen A, Blasiak J, Roider J, Salminen A, Kaarniranta K.
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1457-67. PubMed ID: 23603148
    [Abstract] [Full Text] [Related]

  • 11. [The treatment of the exsudative age-related macular degeneration with choroidal neovascular membrane, its possibilities and economical indexes].
    Karel I.
    Cesk Slov Oftalmol; 2007 Sep; 63(5):311-9. PubMed ID: 17915581
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Age-related macular degeneration.
    Brucker AJ.
    Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
    [Abstract] [Full Text] [Related]

  • 14. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR, Kozak I, Yuson RM, Nigam N, Cheng L, Mojana F.
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anaphylatoxin Signaling in Retinal Pigment and Choroidal Endothelial Cells: Characteristics and Relevance to Age-Related Macular Degeneration.
    Rohrer B.
    Adv Exp Med Biol; 2018 Oct; 1074():45-51. PubMed ID: 29721926
    [Abstract] [Full Text] [Related]

  • 19. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P, van den Bergh H, Sickenberg M, Koh AH.
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [Abstract] [Full Text] [Related]

  • 20. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL.
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.